Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Urologic Oncology|July 31, 2004
The International Bladder Cancer Bank: proposal for a new study conceptPeter J Goebell, Susan Groshen, Bernd J Schmitz-Dräger, et al.
European Urology|August 6, 2013
Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCGMaurizio Brausi, Jorg Oddens, Richard Sylvester, et al.
European Urology|February 25, 2015
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the LiteratureLuis A Kluth, Peter C Black, Bernard H Bochner, et al.
Critical Care Medicine|August 13, 2005
Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis ForumJohn C Marshall, Jean-Louis Vincent, Gordon Guyatt, et al.
Practical Neurology|October 8, 2025
Retired contact sports athletes with cognitive concerns: promoting lifelong brain healthNeil Graham, Martina Del Giovane, Jessica Hain, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2014
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validationBaktiar Hasan, Laurent Greillier, Athanasios Pallis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Prognostic factors for survival in adult patients with cerebral low-grade gliomaFrancesco Pignatti, Martin van den Bent, Desmond Curran, et al.
European Urology|December 5, 2006
A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinomaHendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al.
European Urology|November 13, 2012
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenanceJorg Oddens, Maurizio Brausi, Richard Sylvester, et al.
European Urology|December 28, 2010
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinomaHendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al.
Pageof 9